Influence of Lipid Lowering on Impaired Coronary Flow
Status:
Recruiting
Trial end date:
2025-09-30
Target enrollment:
Participant gender:
Summary
This study assess in patients with stable chest pain and coronary artery disease (CAD)
determined by coronary CTA whether cholesterol lowering with regression of coronary adverse
plaque characteristics is associated with recovery of impaired flow